Dr. Chartoff Image

Elena Chartoff, Ph.D.

Associate Professor of Psychiatry
Harvard Title

Associate Professor of Psychiatry

Other Affiliation

Molecular Pharmacology Laboratory, Mclean Hospital

Address

Mclean Hospital
Molecular Pharmacology Laboratory
115 Mill St  
Belmont MA 02478

Publications View
It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system.
Authors: Chartoff EH, Connery HS.
Front Pharmacol
View full abstract on Pubmed
Synthesis and pharmacological evaluation of aminothiazolomorphinans at the mu and kappa opioid receptors.
Authors: Provencher BA, Sromek AW, Li W, Russell S, Chartoff E, Knapp BI, Bidlack JM, Neumeyer JL.
J Med Chem
View full abstract on Pubmed
Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity.
Authors: Van't Veer A, Bechtholt AJ, Onvani S, Potter D, Wang Y, Liu-Chen LY, Schütz G, Chartoff EH, Rudolph U, Cohen BM, Carlezon WA.
Neuropsychopharmacology
View full abstract on Pubmed
Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression.
Authors: Cone JJ, Chartoff EH, Potter DN, Ebner SR, Roitman MF.
PLoS One
View full abstract on Pubmed
Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats.
Authors: Chartoff E, Sawyer A, Rachlin A, Potter D, Pliakas A, Carlezon WA.
Neuropharmacology
View full abstract on Pubmed
Repeated exposure to the ?-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity.
Authors: Potter DN, Damez-Werno D, Carlezon WA, Cohen BM, Chartoff EH.
Biol Psychiatry
View full abstract on Pubmed
Detection of intranasally delivered bone marrow-derived mesenchymal stromal cells in the lesioned mouse brain: a cautionary report.
Authors: Chartoff EH, Damez-Werno D, Sonntag KC, Hassinger L, Kaufmann DE, Peterson J, McPhie D, Cataldo AM, Cohen BM.
Stem Cells Int
View full abstract on Pubmed
Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens.
Authors: Ebner SR, Roitman MF, Potter DN, Rachlin AB, Chartoff EH.
Psychopharmacology (Berl)
View full abstract on Pubmed
Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.
Authors: Chartoff EH, Barhight MF, Mague SD, Sawyer AM, Carlezon WA.
Psychopharmacology (Berl)
View full abstract on Pubmed
Perspective: Progress on the study and treatment of depressive illness.
Authors: Carlezon WA, Chartoff E.
Neuropsychopharmacology
View full abstract on Pubmed